Efficacy of an Ondansetron Orally Disintegrating Tablet: A Novel Oral Formulation of this 5-HT3 Receptor Antagonist in the Treatment of Fractionated Radiotherapy-Induced Nausea and Emesis

Autor: LeBourgeois, J.P., McKenna, C.J., Coster, B., Feyer, P., Franzén, L., Goedhals, L., Marzecki, Z., Souhami, L., Stewart, A., Tønnessen, F., Haigh, C., Mitchell, T., Wilkinson, J.R., Graham, E.
Zdroj: In Clinical Oncology October 1999 11(5):340-347
Databáze: ScienceDirect